NuCana PLC
Change company Symbol lookup
Select an option...
NCNA NuCana PLC
KO Coca-Cola Co
BAC Bank of America Corp
HXL Hexcel Corp
RDHL Redhill Biopharma Ltd
WASH Washington Trust Bancorp Inc
ADC Agree Realty Corp
FB Facebook Inc
HSTM HealthStream Inc
AMZN Amazon.com Inc
Go

Health Care : Biotechnology |
Based in United KingdomCompany profile

NuCana PLC is a clinical-stage biopharmaceutical company. The Company is focused on improving treatment outcomes for cancer patients by applying its phosphoramidate chemistry technology. The Company utilizes its ProTide technology to develop medicines to overcome cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Its pipeline of products includes Acelarin, NUC-3373 and NUC-7738. Acelarin is a nucleotide analog and is a ProTide transformation of gemcitabine for the treatment of cancer. The Company is evaluating Acelarin in four clinical trials across several solid tumor indications. NUC-3373 is a ProTide transformation of the active anti-cancer metabolite of 5-fluorouracil for the treatment of a wide range of cancers. NUC-3373 is in a Phase I trial for the potential treatment of a wide range of solid tumor cancers. NUC-7738 is a ProTide transformation of cordycepin, a novel nucleoside analog.

Closing Price
$9.10
Day's Change
-0.45 (-4.71%)
Bid
--
Ask
--
B/A Size
--
Day's High
9.65
Day's Low
9.10
Volume
(Light)
Volume:
1,075

10-day average volume:
10,188
1,075
  • Prev Close
    9.55
  • Today's Open
    9.65
  • Day's Range
    9.10-9.65
  • Avg Vol (10-day)
    10.2K
  • Last (time)
    3:57p ET 07/23/19
  • Last (size)
    28
  • 52-Wk Range
    9.03 - 30.10
    LowHigh
  • (08/23/18 - 07/10/19)
    0.78%
  • 79.1%
  • Market Cap
    293.3M
  • Shares Outstanding
    32.2M
  • -0.49
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 38.67
  • (% of float 06/28/19)
    8.59

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.